These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 39151496)

  • 1. Bilateral facial nerve palsy complicating Kawasaki disease: A case report and literature review.
    Ou R; Tan Z; Liu L
    Medicine (Baltimore); 2024 Aug; 103(33):e39389. PubMed ID: 39151496
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Facial nerve palsy may indicate coronary artery lesions in Kawasaki disease.
    Chen J; Liu P; Hu W; Xu Y; Deng J
    Clin Rheumatol; 2021 Oct; 40(10):4191-4197. PubMed ID: 34059986
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kawasaki disease complicating bilateral facial nerve palsy and giant coronary artery aneurysms: A case report.
    Yu X; Liu X; Wang Y; Lu N; Wang M; Sun L
    Medicine (Baltimore); 2019 Feb; 98(7):e14395. PubMed ID: 30762741
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Facial nerve palsy presenting as rare neurological complication of Kawasaki disease: A case report.
    Yuan Y; Lu N
    Medicine (Baltimore); 2019 Aug; 98(34):e16888. PubMed ID: 31441865
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A rare cause of facial nerve palsy in a young infant: Kawasaki disease.
    Orgun A; Karagöl C; Pamuk U; Gürsu HA; Çetin İ
    Turk J Pediatr; 2018; 60(4):433-435. PubMed ID: 30859770
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kawasaki disease with facial nerve paralysis.
    Larralde M; Santos-Muñoz A; Rutiman R
    Pediatr Dermatol; 2003; 20(6):511-3. PubMed ID: 14651572
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Delayed intravenous immunoglobulin treatment increased the risk of coronary artery lesions in children with Kawasaki disease at different status.
    Qiu H; He Y; Rong X; Ren Y; Pan L; Chu M; Wu R; Shi H
    Postgrad Med; 2018 May; 130(4):442-447. PubMed ID: 29745742
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coronary artery aneurysm and facial drooping in a infant with Kawasaki disease.
    Yuan Y; Lu N
    Cardiol Young; 2020 Dec; 30(12):1957-1959. PubMed ID: 32972477
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Infliximab Plus Intravenous Immunoglobulin (IVIG) Versus IVIG Alone as Initial Therapy in Children With Kawasaki Disease Presenting With Coronary Artery Lesions: Is Dual Therapy More Effective?
    Jone PN; Anderson MS; Mulvahill MJ; Heizer H; Glodé MP; Dominguez SR
    Pediatr Infect Dis J; 2018 Oct; 37(10):976-980. PubMed ID: 29461447
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Giant bilateral axillary artery aneurysms with left complete obstructive thrombus in intravenous immunoglobulin-sensitive Kawasaki disease: a case report.
    Chu C; He L; Lin YX; Xie LP; Liu F
    Pediatr Rheumatol Online J; 2021 Nov; 19(1):157. PubMed ID: 34749768
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical outcomes of initial dexamethasone treatment combined with a single high dose of intravenous immunoglobulin for primary treatment of Kawasaki disease.
    Lim YJ; Jung JW
    Yonsei Med J; 2014 Sep; 55(5):1260-6. PubMed ID: 25048483
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of intravenous immunoglobulin resistance and coronary artery lesions in relation to Th1/Th2 cytokine profiles in patients with Kawasaki disease.
    Wang Y; Wang W; Gong F; Fu S; Zhang Q; Hu J; Qi Y; Xie C; Zhang Y
    Arthritis Rheum; 2013 Mar; 65(3):805-14. PubMed ID: 23440694
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictive value of monocyte to HDL-C ratio for coronary artery lesions and intravenous immunoglobulin resistance in Kawasaki disease.
    Wang JR; Zhao HZ; Chang LJ; Xu X; Gao Y; Li M; Kong QY; Wang MM; Zhao CF
    Eur J Pediatr; 2023 Oct; 182(10):4399-4406. PubMed ID: 37480545
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of serum lipid in predicting coronary artery lesions and intravenous immunoglobulin resistance in Kawasaki disease: a cohort study.
    Zhang H; Cai J; Zhang R; Shuai S; Tang M; Ju R; Hu Y; Zuo T; Yang Y
    J Int Med Res; 2024 May; 52(5):3000605241252115. PubMed ID: 38713460
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Facial nerve palsy, Kawasaki disease, and coronary artery aneurysm.
    Stowe RC
    Eur J Paediatr Neurol; 2015 Sep; 19(5):607-9. PubMed ID: 26101056
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Facial palsy in Kawasaki syndrome.
    Bushara K; Wilson A; Rust RS
    Pediatr Neurol; 1997 Nov; 17(4):362-4. PubMed ID: 9436804
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcomes of Kawasaki Disease: A Single-Center Experience.
    Uysal F; Bostan OM; Celebi S; Uysal B; Hamitoglu S; Cil E
    Clin Pediatr (Phila); 2015 Jun; 54(6):579-84. PubMed ID: 25475592
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical relevance of the risk factors for coronary artery lesions in Kawasaki disease.
    Weng KP; Hsieh KS; Huang SH; Ou SF; Ma CY; Ho TY; Lai CR; Ger LP
    Kaohsiung J Med Sci; 2012 Jan; 28(1):23-9. PubMed ID: 22226058
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neonatal Kawasaki disease: Case report and literature review.
    Li C; Du Y; Wang H; Wu G; Zhu X
    Medicine (Baltimore); 2021 Feb; 100(7):e24624. PubMed ID: 33607798
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epidemiology and risk factors for coronary artery abnormalities in children with complete and incomplete Kawasaki disease during a 10-year period.
    Giannouli G; Tzoumaka-Bakoula C; Kopsidas I; Papadogeorgou P; Chrousos GP; Michos A
    Pediatr Cardiol; 2013 Aug; 34(6):1476-81. PubMed ID: 23463134
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.